412 related articles for article (PubMed ID: 33433576)
1. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
Hirai AH; Ko JY; Owens PL; Stocks C; Patrick SW
JAMA; 2021 Jan; 325(2):146-155. PubMed ID: 33433576
[TBL] [Abstract][Full Text] [Related]
2. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.
Patrick SW; Schumacher RE; Benneyworth BD; Krans EE; McAllister JM; Davis MM
JAMA; 2012 May; 307(18):1934-40. PubMed ID: 22546608
[TBL] [Abstract][Full Text] [Related]
3. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
[TBL] [Abstract][Full Text] [Related]
4. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
Hussaini KS; Garcia Saavedra LF
Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses: Analysis of ICD-10-CM Transition, 2013-2017.
Ko JY; Hirai AH; Owens PL; Stocks C; Patrick SW
Hosp Pediatr; 2021 Aug; 11(8):902-908. PubMed ID: 34321311
[TBL] [Abstract][Full Text] [Related]
6. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
[TBL] [Abstract][Full Text] [Related]
7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.
Ko JY; Patrick SW; Tong VT; Patel R; Lind JN; Barfield WD
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(31):799-802. PubMed ID: 27513154
[TBL] [Abstract][Full Text] [Related]
9. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital Births.
Short VL; Gannon M; Abatemarco DJ
Breastfeed Med; 2016 Sep; 11():343-9. PubMed ID: 27529500
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of neonatal abstinence syndrome in the United States.
Corr TE; Hollenbeak CS
Addiction; 2017 Sep; 112(9):1590-1599. PubMed ID: 28612362
[TBL] [Abstract][Full Text] [Related]
12. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
13. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis.
Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C
Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System.
West KD; Ali MM; Blanco M; Natzke B; Nguyen L
Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.
Patrick SW; Davis MM; Lehmann CU; Cooper WO
J Perinatol; 2015 Aug; 35(8):650-5. PubMed ID: 25927272
[TBL] [Abstract][Full Text] [Related]
16. Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study.
Plouffe R; Grywacheski V; Luo W; Nelson C; Orpana H
Can J Public Health; 2023 Apr; 114(2):277-286. PubMed ID: 36482143
[TBL] [Abstract][Full Text] [Related]
17. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
[TBL] [Abstract][Full Text] [Related]
18. A Longitudinal Healthcare Use Profile of Children with a History of Neonatal Abstinence Syndrome.
Liu G; Kong L; Leslie DL; Corr TE
J Pediatr; 2019 Jan; 204():111-117.e1. PubMed ID: 30270164
[TBL] [Abstract][Full Text] [Related]
19. A state-level study of opioid use disorder treatment access and neonatal abstinence syndrome.
Wolf ER; Tong ST; Sabo RT; Woolf SH; Abbinanti K; Pecsok J; Krist AH
BMC Pediatr; 2019 Oct; 19(1):371. PubMed ID: 31640614
[TBL] [Abstract][Full Text] [Related]
20. Infant and maternal characteristics in neonatal abstinence syndrome--selected hospitals in Florida, 2010-2011.
Lind JN; Petersen EE; Lederer PA; Phillips-Bell GS; Perrine CG; Li R; Hudak M; Correia JA; Creanga AA; Sappenfield WM; Curran J; Blackmore C; Watkins SM; Anjohrin S;
MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(8):213-6. PubMed ID: 25742381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
